![Gerald Pier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Gerald B. Pier is the founder of Alopexx, Inc., founded in 2006, holding the title of Director & Chief Scientific Advisor.
Dr. Pier is also the founder of Alopexx Enterprises LLC.
Dr. Pier currently holds the position of Professor at Harvard Medical School.
Dr. Pier earned a doctorate from the University of California, Berkeley and completed undergraduate studies at the University of the Pacific.
Aktiva positioner av Gerald Pier
| Företag | Position | Start |
|---|---|---|
| ALOPEXX, INC. | Grundare | 2006-01-01 |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
Alopexx Enterprises LLC
 Alopexx Enterprises LLC BiotechnologyHealth Technology Engages in investing and managing health care companies | Grundare | - |
Gerald Piers utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
88
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of the Pacific
 University of the Pacific Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alopexx Enterprises LLC
Alopexx Enterprises LLC BiotechnologyHealth Technology Engages in investing and managing health care companies | Health Technology |
Alopexx, Inc.
 Alopexx, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company which develops novel and broad-spectrum immune-mediated therapeutics | Health Technology |
